Novel epiHERA® methodology optimizes sample acquisition, significantly reducing turnaround time from weeks to days, enabling equitable access to critical diagnostics ...
Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale...
The incubator aims to advance healthcare innovations by fostering a thriving ecosystem for biomedtech startups...
An aero-elastic sensor that revolutionises the way pressure is detected...
First microarray-based solution in Singapore to enable multi-gene panel testing for pharmacogenomics and disease risk assessment...
GASTROClear is the first miRNA blood test and the first gastric cancer molecular test globally to receive FDA Breakthrough Device Designation...
Renewing focus on primary and preventive health in medical training...
Yashoda Medicity, the upcoming healthcare facility by Yashoda Foundations in Indirapuram, is collaborating with Draeger India, a renowned global medical and safety technology solutions provider. Yashoda Medicity is the new addition to the renowned healthcare institution Yashoda Super Speciality Hospital, well acknowledged for its exceptional patient care and facilities. Together, Yashoda Medicity and Dräger are embarking on a groundbreaking initiative to establish one of the largest modular Int...
It is estimated that over 7% of the population in Southeast Asia suffer from Chronic Respiratory Disease with asthma and COPD amongst the most common chronic respiratory diseases...
Aevice Health, a leading provider of remote respiratory monitoring solutions for the healthcare continuum and backed by the Cedars-Sinai Accelerator, announced that its flagship medical device, the AeviceMD, has received clearance from the U.S. Food and Drug Administration (FDA) as a Class II medical device under the 510(k) route....